SUBSTITUTED 4-[5-(BENZOFURAN-2-YL)-1,2,4-OXADIAZOL-3-YL]BENZOIC ACID COMPOUNDS FOR USE IN THERAPY FOR NEUROPATHIC PAIN
The present invention pertains generally to the field of therapy. More specifically, the present invention pertains to certain substituted 4-[5-(benzofuran-2-yl)-1,2,4-oxadiazol-3-yl]benzoic acid compounds (collectively referred to herein as BOBA compounds), and pharmaceutical compositions comprisin...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
03.12.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention pertains generally to the field of therapy. More specifically, the present invention pertains to certain substituted 4-[5-(benzofuran-2-yl)-1,2,4-oxadiazol-3-yl]benzoic acid compounds (collectively referred to herein as BOBA compounds), and pharmaceutical compositions comprising those compounds, for use in a method of treatment or prevention of neuropathic pain. (Formula (A))
La présente invention concerne de manière générale le domaine thérapeutique. Plus spécifiquement, la présente invention concerne certains composés d'acide 4-[5-(benzofuran-2-yl)-1,2,4-oxadiazol-3-yl]benzoïque substitué (désignés collectivement ici en tant que composés BOBA), et des compositions pharmaceutiques comprenant ces composés, pour utilisation dans une méthode de traitement ou de prévention de la douleur neuropathique. (Formule (A)) |
---|---|
Bibliography: | Application Number: WO2020EP64969 |